Successful Management of Tardive Dyskinesia with Quetiapine and Clonazepam in a Patient of Schizophrenia with Type 2 Diabetes Mellitus.
10.9758/cpn.2016.14.2.218
- Author:
Satyakam MOHAPATRA
1
Author Information
1. Mental Health Institute, S.C.B. Medical College, Cuttack, India. satyakgmu@gmail.com
- Publication Type:Case Report
- Keywords:
Movement disorders;
Quetiapine;
Schizophrenia;
Diabetes mellitus
- MeSH:
Adult;
Clonazepam*;
Clozapine;
Diabetes Mellitus;
Diabetes Mellitus, Type 2*;
Diagnosis;
Glucose;
Humans;
Male;
Movement Disorders*;
Schizophrenia*;
Quetiapine Fumarate
- From:Clinical Psychopharmacology and Neuroscience
2016;14(2):218-220
- CountryRepublic of Korea
- Language:English
-
Abstract:
Tardive dyskinesia is one of the most significant side effects of antipsychotic medications. Antipsychotic treated schizophrenia patients with diabetes mellitus are more likely to develop tardive dyskinesia than those without diabetes. Clozapine is probably best supported for management of tardive dyskinesia. But clozapine has been strongly linked to hyperglycaemia and impaired glucose tolerance, so it is not preferred in patients with diabetes mellitus. We present a case of 35-year-old male with a diagnosis of schizophrenia and type 2 diabetes mellitus with tardive dyskinesia, who was successfully treated with quetiapine and clonazepam.
